NYRADA INC (ASX:NYR) 52 14. Subsidiaries 2025 ownership interest 2024 ownership interest Nyrada Pty Ltd 100% 100% Norbio No.2 Pty Ltd 100% 100% Cardio Therapeutics Pty Ltd 100% 100% 15. Events after reporting period On 4 August, 433,333 CDIs were issued as a result of options exercised at $0.135 per CDI. On 4 August 2025, 105,000 CDIs were issued for the provision of services at an agreed rate of $0.24 per CDI. On 4 August 2025, the Consolidated entity announced it received firm commitments for a placement of 27.5million Chess Depositary Instruments (CDIs), raising $8.25 million in new equity capital from new and existing institutional, professional and sophisticated investors (Placement). The Placement issue price was $0.30 per CDI. On 11 August 2025, 26,200,000 CDIs were issued at $0.30 per CDI in connection with the Placement announced on 4 August 2025. On 11 August 2025, 150,000 CDIs were issued as a result of options exercised at $0.135 per CDI. 16. Cash flow information Reconciliation of loss after income tax to net cash used in operating activities 2025 2024 $ $ Loss after income tax expense for the year (4,845,671) (1,391,309) Adjustments for: Depreciation & amortisation 3,777 5,183 Share-based payments 177,218 358,074 Change in operating assets and liabilities Decrease/(increase) in trade and other receivables (1,235,520) 312,890 Increase/(decrease) in trade and other payables 802,095 (62,981) Increase/(decrease) in employee benefits 46,154 11,848 (5,051,947) (766,295) Reconciliation of Cash Cash at the end of financial year as included in the statement of cash flows is reconciled to the related items in the statement of financial position as follows: 2025 2024 $ $ Cheque account 40,501 56,034 USD account 118,993 388 Saving bonus 2,771,107 2,212,952 Term deposit - 2,500,000 2,930,601 4,769,374
RkJQdWJsaXNoZXIy MjE2NDg3